Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients [3]

Annals of Oncology

Volumn 17, Issue 4, 2006, Pages 721-722

  Berretta, M ^a   Simonelli, C ^a   Lleshi, A ^a   Lacchin, T ^a   Bearz, A ^a   di Gennaro, G ^a   Vaccher, E ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABSENCE OF SIDE EFFECTS; BLOOD CELL COUNT; BLOOD CHEMISTRY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LETTER; LIVER METASTASIS; MALE; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VIRUS LOAD;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COLORECTAL NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS;

EID: 33645293148     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj061     Document Type: Letter

References (4)

1. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin N Am 2003; 17: 889-899.
2. Bonnet F, Lewden C, May T et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-324.
3. Cerosimo RJ. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother 2005; 39: 128-135.
4. Andre T, Bensmaine MA, Louvet C et al. Multicenter phase II study of bimonthly high dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 1999; 17: 3560-3568.